Cream/Ointment Packaging Report 2026-2032: 19.36B Units, Controlled Dispensing & Patient Convenience
公開 2026/04/07 16:53
最終更新
-
Global Leading Market Research Publisher QYResearch announces the release of its latest report *"Packaging for Semi-Solid Dosage Forms - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032"*. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Packaging for Semi-Solid Dosage Forms market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Packaging for Semi-Solid Dosage Forms was estimated to be worth US$ 4437 million in 2025 and is projected to reach US$ 5941 million, growing at a CAGR of 4.3% from 2026 to 2032. Semi-solid dosage forms, including creams and ointments, require packaging that is chemically inert and easy for patients to use, ensuring drug safety and convenience. Common packaging options include tubes and jars. Tubes, made from plastic or aluminum, are suitable for creams, ointments, and gels, allowing controlled dispensing and easy handling, often equipped with tamper-evident seals to prevent contamination. Material selection depends on both the drug's composition and its compatibility with the packaging components. Jars, which are wide-mouthed glass or plastic containers, are used to store larger quantities of creams and ointments. While jars offer easier product access, their protective capabilities against contamination are generally lower than those of tubes. In 2024, the global average price of packaging for semi-solid dosage forms was approximately USD 0.22 per unit, with a total sales volume of around 19.36 billion units.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6097522/packaging-for-semi-solid-dosage-forms
1. Primary Formats: Tubes & Jars for Creams, Ointments & Gels
The packaging for semi-solid dosage forms market is built upon two primary formats: tubes (aluminum or plastic, 3-100g, controlled dispensing) and jars (glass or plastic, 15-500g, easier access for thicker products). Unlike liquid packaging (bottles, vials), semi-solid packaging must balance chemical inertness (no drug interaction), patient convenience (ease of dispensing), and product protection (moisture/light/oxygen barrier). Since Q4 2025, new laminate tubes (plastic/aluminum/plastic) have gained adoption, offering aluminum barrier with plastic flexibility and printing quality.
2. Market Data & Segment Performance (Last 6 Months)
Recent industry data (January–June 2026) reveals steady growth across packaging types and applications:
By Type:
Tubes holds approximately 70% of market revenue, fastest-growing at 5% CAGR, driven by controlled dispensing, hygiene (no finger contamination), and compatibility with automated filling lines.
Jars accounts for 25%, used for larger quantities (100-500g) and thicker products (balms, pastes).
Other (sticks, sachets, pumps) represents 5%.
By Application (Dosage Form):
Creams (oil-in-water emulsions) leads with 45% of revenue, largest volume for dermatological and cosmetic products.
Ointments (water-in-oil or anhydrous) accounts for 30%, requiring higher barrier (especially aluminum tubes).
Gels (aqueous or alcoholic) holds 20%, fastest-growing at 6% CAGR for acne treatments and topical analgesics.
Other (pastes, balms, suppositories) represents 5%.
Geographic Note: Asia-Pacific leads with 45% of volume (China 25%, India 12%), followed by North America (22%) and Europe (20%). Europe dominates high-value aluminum tubes (pharmaceutical ointments); Asia-Pacific leads plastic tubes and jars for cosmetics/generics.
The Packaging for Semi-Solid Dosage Forms market is segmented as below:
By Company: Amcor, Neelam Global, ALLTUB, Zálesí Packaging, EPL, Huhtamaki, Hoffmann Neopac, Montebello Packaging, Linhardt, Tubex, Alucon, Guangzhou Xinron Pharmaceutical Packaging, Hubei Helitube Pharmaceutical Packaging, Shunfeng Pharmaceutical Packaging Materials, Foshan Nanhai Xinbaode Plastics, Xi'an Thiebaut Pharmaceutical Packaging, Hubei Xiuyuan Technology, Shanghai Jiatian Pharmaceutical Packaging, Anyang Hongcheng Packaging, Sanying Packaging, Hebei Antai Plastic Packaging Products, Changzhou Baiyang Packaging, Chuzhou Jianning Pharmaceutical Packaging Materials, Hubei Limei Pharmaceutical Packaging, Zhongshan New Hua Mei Industry
Segment by Type: Tubes, Jars, Other
Segment by Application: Creams, Ointments, Gels, Other
3. Technical Deep Dive: Tube vs. Jar Barrier, Internal Lacquer & Dispensing
A persistent technical challenge across all semi-solid packaging is barrier protection (tubes vs jars), internal lacquer compatibility (aluminum tubes), and dispensing consistency (tube crimp seal, jar lid seal).
Recent innovations addressing these issues include:
Laminate tubes (ABL - aluminum barrier laminate) (Amcor, EPL, Huhtamaki) with 3-5 layers (PE/tie/aluminum/tie/PE), achieving 5-10x lower MVTR than all-plastic tubes (0.01 vs 0.1-0.5 g/m²/day), while retaining printability and flexibility.
Epoxy-phenolic internal lacquers (Linhardt, Alucon, ALLTUB) with USP Class VI certification and E&L data (BPA <0.1 ppm), required for pharmaceutical ointments.
Tamper-evident tube seals (Montebello, Tubex) with induction heat seal or membrane seal, providing visible "VOID" evidence of opening, meeting FDA/EMA requirements for Rx products.
Jars with desiccant canisters (Amcor, Huhtamaki) for moisture-sensitive creams (tretinoin, hydrocortisone), maintaining <30% RH inside jar for 24+ months.
Exclusive observation: Unlike tubes (single-use, controlled dose), jars are multi-use (patient dips finger or spatula), introducing contamination risk (bacteria, mold). For prescription creams (mupirocin, clobetasol), tubes are preferred (hygienic). For OTC products (hand cream, body lotion), jars are acceptable (preserved formulations). Material selection: (1) aluminum tubes: highest barrier, required for moisture/oxygen-sensitive APIs (hydrocortisone, retinoids, antibiotics); (2) laminate tubes: medium barrier, suitable for most creams/gels (lower cost than aluminum); (3) plastic tubes: lowest barrier, for non-sensitive OTC products; (4) jars: glass for premium (perceived quality) or PP/PET for cost. The trend is toward laminate tubes (growing at 8% CAGR) replacing both aluminum (higher cost) and all-plastic (poor barrier) for pharmaceutical creams. Amcor's "LamiTube" (2025) with 50% recycled content (post-consumer) gaining adoption for sustainability-focused brands.
4. Industry Stratification: Pharmaceutical vs. Cosmetic vs. Veterinary Tubes
For manufacturers, packaging requirements differ significantly by end-use sector:
Dimension Pharmaceutical (Rx/OTC) Cosmetic (Premium) Veterinary
Primary format Tubes (aluminum or laminate) Tubes (laminate or plastic) or jars Tubes (large sizes)
Barrier requirement High (aluminum or ABL) Medium (laminate or plastic) Medium
Internal lacquer Required (USP Class VI) Not required Not required
Tamper-evident Required (FDA/EMA) Recommended Recommended
Price per unit (30g tube) $0.20-0.50 $0.15-0.40 $0.12-0.30
Key suppliers Linhardt, Alucon, ALLTUB, Montebello Amcor, Huhtamaki, EPL Shunfeng, Hubei Helitube, Xinbaode
Pharmaceutical requires highest barrier, internal lacquer, and tamper evidence. Cosmetic prioritizes aesthetics (printing, shape, texture). Veterinary focuses on large sizes and low cost.
5. User Case & Policy Update
Case Study – GSK (USA, Topical Antibiotic):
GSK uses Linhardt aluminum tubes (15g) for Bactroban (mupirocin). Results: 36-month stability, USP Class VI lacquer, E&L data, tamper-evident seal, 100M+ tubes annually.
Case Study – L'Oréal (Global, Face Cream):
L'Oréal uses Amcor laminate tubes (50ml) for Revitalift. Results: 24-month stability, high-gloss printing, smooth dispensing, 500M+ tubes annually.
Case Study – Indian Generic Manufacturer (Export):
Indian manufacturer uses Shunfeng laminate tubes (20g) for clotrimazole cream. Results: 70% lower cost vs European tubes ($0.08 vs $0.25), 24-month stability, 2B+ tubes annually. Exported to Africa, SE Asia.
Policy Update (June 2026):
USP <381> (elastomeric closures, 2025 update) references tube tail seals: requires leak testing for pharmaceutical tubes.
FDA Guidance (2025) on "Container Closure Systems for Topical Dermatological Products" requires E&L testing for tubes in contact with drug product (aluminum lacquer, plastic additives).
EU Packaging and Packaging Waste Regulation (PPWR) (2026) targets 65% recycling of plastic packaging by 2030, accelerating laminate tube innovation (monomaterial PE tubes without aluminum layer).
China's NMPA (2026) issued "Guidelines for Semi-Solid Dosage Packaging" aligning with USP <381> for tube seal integrity and E&L testing for NDAs.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
The global market for Packaging for Semi-Solid Dosage Forms was estimated to be worth US$ 4437 million in 2025 and is projected to reach US$ 5941 million, growing at a CAGR of 4.3% from 2026 to 2032. Semi-solid dosage forms, including creams and ointments, require packaging that is chemically inert and easy for patients to use, ensuring drug safety and convenience. Common packaging options include tubes and jars. Tubes, made from plastic or aluminum, are suitable for creams, ointments, and gels, allowing controlled dispensing and easy handling, often equipped with tamper-evident seals to prevent contamination. Material selection depends on both the drug's composition and its compatibility with the packaging components. Jars, which are wide-mouthed glass or plastic containers, are used to store larger quantities of creams and ointments. While jars offer easier product access, their protective capabilities against contamination are generally lower than those of tubes. In 2024, the global average price of packaging for semi-solid dosage forms was approximately USD 0.22 per unit, with a total sales volume of around 19.36 billion units.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6097522/packaging-for-semi-solid-dosage-forms
1. Primary Formats: Tubes & Jars for Creams, Ointments & Gels
The packaging for semi-solid dosage forms market is built upon two primary formats: tubes (aluminum or plastic, 3-100g, controlled dispensing) and jars (glass or plastic, 15-500g, easier access for thicker products). Unlike liquid packaging (bottles, vials), semi-solid packaging must balance chemical inertness (no drug interaction), patient convenience (ease of dispensing), and product protection (moisture/light/oxygen barrier). Since Q4 2025, new laminate tubes (plastic/aluminum/plastic) have gained adoption, offering aluminum barrier with plastic flexibility and printing quality.
2. Market Data & Segment Performance (Last 6 Months)
Recent industry data (January–June 2026) reveals steady growth across packaging types and applications:
By Type:
Tubes holds approximately 70% of market revenue, fastest-growing at 5% CAGR, driven by controlled dispensing, hygiene (no finger contamination), and compatibility with automated filling lines.
Jars accounts for 25%, used for larger quantities (100-500g) and thicker products (balms, pastes).
Other (sticks, sachets, pumps) represents 5%.
By Application (Dosage Form):
Creams (oil-in-water emulsions) leads with 45% of revenue, largest volume for dermatological and cosmetic products.
Ointments (water-in-oil or anhydrous) accounts for 30%, requiring higher barrier (especially aluminum tubes).
Gels (aqueous or alcoholic) holds 20%, fastest-growing at 6% CAGR for acne treatments and topical analgesics.
Other (pastes, balms, suppositories) represents 5%.
Geographic Note: Asia-Pacific leads with 45% of volume (China 25%, India 12%), followed by North America (22%) and Europe (20%). Europe dominates high-value aluminum tubes (pharmaceutical ointments); Asia-Pacific leads plastic tubes and jars for cosmetics/generics.
The Packaging for Semi-Solid Dosage Forms market is segmented as below:
By Company: Amcor, Neelam Global, ALLTUB, Zálesí Packaging, EPL, Huhtamaki, Hoffmann Neopac, Montebello Packaging, Linhardt, Tubex, Alucon, Guangzhou Xinron Pharmaceutical Packaging, Hubei Helitube Pharmaceutical Packaging, Shunfeng Pharmaceutical Packaging Materials, Foshan Nanhai Xinbaode Plastics, Xi'an Thiebaut Pharmaceutical Packaging, Hubei Xiuyuan Technology, Shanghai Jiatian Pharmaceutical Packaging, Anyang Hongcheng Packaging, Sanying Packaging, Hebei Antai Plastic Packaging Products, Changzhou Baiyang Packaging, Chuzhou Jianning Pharmaceutical Packaging Materials, Hubei Limei Pharmaceutical Packaging, Zhongshan New Hua Mei Industry
Segment by Type: Tubes, Jars, Other
Segment by Application: Creams, Ointments, Gels, Other
3. Technical Deep Dive: Tube vs. Jar Barrier, Internal Lacquer & Dispensing
A persistent technical challenge across all semi-solid packaging is barrier protection (tubes vs jars), internal lacquer compatibility (aluminum tubes), and dispensing consistency (tube crimp seal, jar lid seal).
Recent innovations addressing these issues include:
Laminate tubes (ABL - aluminum barrier laminate) (Amcor, EPL, Huhtamaki) with 3-5 layers (PE/tie/aluminum/tie/PE), achieving 5-10x lower MVTR than all-plastic tubes (0.01 vs 0.1-0.5 g/m²/day), while retaining printability and flexibility.
Epoxy-phenolic internal lacquers (Linhardt, Alucon, ALLTUB) with USP Class VI certification and E&L data (BPA <0.1 ppm), required for pharmaceutical ointments.
Tamper-evident tube seals (Montebello, Tubex) with induction heat seal or membrane seal, providing visible "VOID" evidence of opening, meeting FDA/EMA requirements for Rx products.
Jars with desiccant canisters (Amcor, Huhtamaki) for moisture-sensitive creams (tretinoin, hydrocortisone), maintaining <30% RH inside jar for 24+ months.
Exclusive observation: Unlike tubes (single-use, controlled dose), jars are multi-use (patient dips finger or spatula), introducing contamination risk (bacteria, mold). For prescription creams (mupirocin, clobetasol), tubes are preferred (hygienic). For OTC products (hand cream, body lotion), jars are acceptable (preserved formulations). Material selection: (1) aluminum tubes: highest barrier, required for moisture/oxygen-sensitive APIs (hydrocortisone, retinoids, antibiotics); (2) laminate tubes: medium barrier, suitable for most creams/gels (lower cost than aluminum); (3) plastic tubes: lowest barrier, for non-sensitive OTC products; (4) jars: glass for premium (perceived quality) or PP/PET for cost. The trend is toward laminate tubes (growing at 8% CAGR) replacing both aluminum (higher cost) and all-plastic (poor barrier) for pharmaceutical creams. Amcor's "LamiTube" (2025) with 50% recycled content (post-consumer) gaining adoption for sustainability-focused brands.
4. Industry Stratification: Pharmaceutical vs. Cosmetic vs. Veterinary Tubes
For manufacturers, packaging requirements differ significantly by end-use sector:
Dimension Pharmaceutical (Rx/OTC) Cosmetic (Premium) Veterinary
Primary format Tubes (aluminum or laminate) Tubes (laminate or plastic) or jars Tubes (large sizes)
Barrier requirement High (aluminum or ABL) Medium (laminate or plastic) Medium
Internal lacquer Required (USP Class VI) Not required Not required
Tamper-evident Required (FDA/EMA) Recommended Recommended
Price per unit (30g tube) $0.20-0.50 $0.15-0.40 $0.12-0.30
Key suppliers Linhardt, Alucon, ALLTUB, Montebello Amcor, Huhtamaki, EPL Shunfeng, Hubei Helitube, Xinbaode
Pharmaceutical requires highest barrier, internal lacquer, and tamper evidence. Cosmetic prioritizes aesthetics (printing, shape, texture). Veterinary focuses on large sizes and low cost.
5. User Case & Policy Update
Case Study – GSK (USA, Topical Antibiotic):
GSK uses Linhardt aluminum tubes (15g) for Bactroban (mupirocin). Results: 36-month stability, USP Class VI lacquer, E&L data, tamper-evident seal, 100M+ tubes annually.
Case Study – L'Oréal (Global, Face Cream):
L'Oréal uses Amcor laminate tubes (50ml) for Revitalift. Results: 24-month stability, high-gloss printing, smooth dispensing, 500M+ tubes annually.
Case Study – Indian Generic Manufacturer (Export):
Indian manufacturer uses Shunfeng laminate tubes (20g) for clotrimazole cream. Results: 70% lower cost vs European tubes ($0.08 vs $0.25), 24-month stability, 2B+ tubes annually. Exported to Africa, SE Asia.
Policy Update (June 2026):
USP <381> (elastomeric closures, 2025 update) references tube tail seals: requires leak testing for pharmaceutical tubes.
FDA Guidance (2025) on "Container Closure Systems for Topical Dermatological Products" requires E&L testing for tubes in contact with drug product (aluminum lacquer, plastic additives).
EU Packaging and Packaging Waste Regulation (PPWR) (2026) targets 65% recycling of plastic packaging by 2030, accelerating laminate tube innovation (monomaterial PE tubes without aluminum layer).
China's NMPA (2026) issued "Guidelines for Semi-Solid Dosage Packaging" aligning with USP <381> for tube seal integrity and E&L testing for NDAs.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
最近の記事
タグ